DiaMedica Therapeutics (DMAC) Tax Provisions: 2018-2024

Historic Tax Provisions for DiaMedica Therapeutics (DMAC) over the last 7 years, with Dec 2024 value amounting to $30,000.

  • DiaMedica Therapeutics' Tax Provisions fell 66.67% to $2,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $31,000, marking a year-over-year decrease of 61.25%. This contributed to the annual value of $30,000 for FY2024, which is 30.23% down from last year.
  • Per DiaMedica Therapeutics' latest filing, its Tax Provisions stood at $30,000 for FY2024, which was down 30.23% from $43,000 recorded in FY2023.
  • DiaMedica Therapeutics' Tax Provisions' 5-year high stood at $43,000 during FY2023, with a 5-year trough of $27,000 in FY2020.
  • Moreover, its 3-year median value for Tax Provisions was $30,000 (2024), whereas its average is $33,667.
  • Per our database at Business Quant, DiaMedica Therapeutics' Tax Provisions spiked by 53.57% in 2023 and then slumped by 30.23% in 2024.
  • DiaMedica Therapeutics' Tax Provisions (Yearly) stood at $27,000 in 2020, then climbed by 3.70% to $28,000 in 2021, then remained steady at $28,000 in 2022, then spiked by 53.57% to $43,000 in 2023, then tumbled by 30.23% to $30,000 in 2024.